| Product Code: ETC7542059 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The drug-resistant epilepsy market import shipment in India experienced significant growth with a remarkable CAGR from 2020 to 2024. The growth rate surged notably between 2023 and 2024, indicating accelerating momentum. The market expanded consistently over the period, showing a strong upward trend.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Drug-Resistant Epilepsy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Drug-Resistant Epilepsy Market Revenues & Volume, 2021 & 2031F |
3.3 India Drug-Resistant Epilepsy Market - Industry Life Cycle |
3.4 India Drug-Resistant Epilepsy Market - Porter's Five Forces |
3.5 India Drug-Resistant Epilepsy Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 India Drug-Resistant Epilepsy Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 India Drug-Resistant Epilepsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of drug-resistant epilepsy in India |
4.2.2 Growing awareness about advanced treatment options for drug-resistant epilepsy |
4.2.3 Rise in healthcare infrastructure and facilities in India |
4.3 Market Restraints |
4.3.1 High cost associated with advanced treatment options for drug-resistant epilepsy |
4.3.2 Limited availability of specialists and resources for managing drug-resistant epilepsy effectively in India |
5 India Drug-Resistant Epilepsy Market Trends |
6 India Drug-Resistant Epilepsy Market, By Types |
6.1 India Drug-Resistant Epilepsy Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 India Drug-Resistant Epilepsy Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 India Drug-Resistant Epilepsy Market Revenues & Volume, By Neuromodulation Therapy, 2021- 2031F |
6.1.4 India Drug-Resistant Epilepsy Market Revenues & Volume, By Antiseizure Medications, 2021- 2031F |
6.1.5 India Drug-Resistant Epilepsy Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.1.6 India Drug-Resistant Epilepsy Market Revenues & Volume, By Resective Epilepsy Surgery, 2021- 2031F |
6.1.7 India Drug-Resistant Epilepsy Market Revenues & Volume, By Specific Metabolic Treatment, 2021- 2031F |
6.1.8 India Drug-Resistant Epilepsy Market Revenues & Volume, By Specific Genetic Treatment, 2021- 2031F |
6.2 India Drug-Resistant Epilepsy Market, By End-users |
6.2.1 Overview and Analysis |
6.2.2 India Drug-Resistant Epilepsy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 India Drug-Resistant Epilepsy Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 India Drug-Resistant Epilepsy Market Revenues & Volume, By Others, 2021- 2031F |
7 India Drug-Resistant Epilepsy Market Import-Export Trade Statistics |
7.1 India Drug-Resistant Epilepsy Market Export to Major Countries |
7.2 India Drug-Resistant Epilepsy Market Imports from Major Countries |
8 India Drug-Resistant Epilepsy Market Key Performance Indicators |
8.1 Patient adherence to prescribed treatment regimens |
8.2 Number of clinical trials and research studies on drug-resistant epilepsy in India |
8.3 Percentage of patients achieving seizure control with advanced treatment options |
9 India Drug-Resistant Epilepsy Market - Opportunity Assessment |
9.1 India Drug-Resistant Epilepsy Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 India Drug-Resistant Epilepsy Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 India Drug-Resistant Epilepsy Market - Competitive Landscape |
10.1 India Drug-Resistant Epilepsy Market Revenue Share, By Companies, 2024 |
10.2 India Drug-Resistant Epilepsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here